Rajiv Gandhi Cancer Institute to provide free treatment to EWS patients in OPD, IPD from March 1
“In light of the statement, the hospital is directed to provide 25 percent OPD and 10 percent IPD to EWS patients. The petition is disposed of,” the bench, also comprising Justice Subramonium Prasad, said.;
Delhi High Court
New Delhi: The Rajiv Gandhi Cancer Institute told the Delhi High Court on Wednesday that it will start providing free treatment to poor patients to the extent of 25 per cent in the out-patient department (OPD) and 10 per cent in the in-patient department (IPD) from March 1.
The statement was made by the hospital’s counsel before a bench headed by Chief Justice Satish Chandra Sharma on a public interest litigation, which had alleged that the institute had not provided free treatment to poor patients in the last two decades.
The court took the hospital’s voluntary stand on record and directed it to provide treatment to the poor as undertaken by it.
“In light of the statement, the hospital is directed to provide 25 percent OPD and 10 percent IPD to EWS patients. The petition is disposed of,” the bench, also comprising Justice Subramonium Prasad, said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.